News
Kudelski IoT Labs Becomes Amazon Authorized Test Lab for Alexa Voice Services (AVS) for Built-in Devices
The Kudelski Group (SIX: KUD.S), the world leader in digital security, today announced that it has become an Amazon-authorized, third-party test lab for Alexa Built-in devices. These devices
Vifor Pharma Appoints Gregory Oakes as President North America and Member of the Executive Committee
Regulatory News:
Vifor Pharma today announced the appointment of Gregory Oakes as EVP, President North America and member of the Vifor Pharma Executive Committee as of September 1, 2020.
Vifor Pharma Group Reports Continued Growth in H1 2020
Regulatory News:
Vifor Pharma Group reported growth in H1 2020, despite challenges to patient access conditions caused by the COVID-19 pandemic. The financial guidance has been updated to reflect
Vifor Pharma Gruppe wächst auch im 1. Halbjahr 2020 weiter
Regulatory News:
Die Vifor Pharma Gruppe ist trotz der Herausforderungen, die Patienten auch während der COVID-19-Pandemie zu erreichen, im 1. Halbjahr 2020 weiter gewachsen. Die Finanzprognose
Three UBS Advisors in the Greater New England Market Named to Forbes/SHOOK Top Next-Gen Wealth Advisors list
UBS is proud to announce that three financial advisors in the Firm’s Greater New England Market have been named to Forbes/SHOOK Top Next-Gen Wealth Advisors list for 2020. Those recognized include
ABB Appoints Theodor Swedjemark as Chief Communications Officer
As of August 1, 2020, Theodor Swedjemark (40) will join the Executive Committee of ABB as the company’s Chief Communications Officer. Swedjemark has held the position on an interim basis since
ABB to Launch Share Buyback Program
Following the completion of the divestment of its Power Grids business to Hitachi on July 1, 2020, and consistent with its overall capital structure optimization program, ABB will launch its
ABB: Q2 2020 Results
“As expected, the second quarter has been heavily impacted by COVID-19. At the same time, we were very focused on cost mitigation efforts which provided some resilience. Operational margins for the
ABB completes divestment of Power Grids to Hitachi
ABB today reached a significant milestone in the company’s transformation towards a decentralized global technology company, with the completion of the divestment of 80.1 percent of its Power Grids
Synthace and Tecan Announce Collaboration to Accelerate Purification Optimization in Process Development through Augmented Lab Automation
Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rate of biological processes, and the Tecan Group (SIX Swiss Exchange: TECN)
ABB: Our Way forward
ABB will be hosting an investor webcast at 14:00 CEST today, June 10, at which CEO, Björn Rosengren, will be giving his initial impressions on the Group’s strategy since he joined the company at
VFMCRP and ChemoCentryx announce topline data from phase-II LUMINA-1 trial of CCX140 in Focal Segmental Glomerulosclerosis (FSGS)
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200517005052/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
92. Generalversammlung der Vifor Pharma Gruppe
Regulatory News:
An der 92. ordentlichen Generalversammlung der Vifor Pharma AG haben die Aktionäre alle Beschlussanträge des Verwaltungsrats genehmigt.
Aufgrund der aktuellen Situation und im
92nd Vifor Pharma Group Annual General Meeting
Regulatory News:
At the 92nd Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors.
In view of the current situation
Vifor Pharma Announces Akebia’s Positive Top-Line Results From Global Phase-III Program of vadadustat for Treatment of Anaemia Due to Chronic Kidney Disease in Adult Dialysis-Dependent Patients
Regulatory News:
Vifor Pharma announced that its partner, Akebia Therapeutics, Inc., today reported positive top-line results from INNO2VATE, Akebia’s global phase-III cardiovascular outcomes
Kudelski and CoreKinect to Enable Secure Tracking and Monitoring of Medical Assets During COVID-19 and Beyond
The Kudelski Group (SIX: KUD.S), the world leader in digital security, and CoreKinect, a leader in scalable hardware design & manufacturing, today announced the launch of a joint solution enabling
Three UBS Greater New England Advisors Named to 2020 Forbes/SHOOK List of Top Women Wealth Advisors
UBS Financial Services Inc. announced yesterday that three Financial Advisors in the Firm's Greater New England Market have been named to Forbes/SHOOK list of Top Women Wealth Advisors, listed on w
ABB: Q1 2020 Results
“The COVID-19 pandemic impacted our first quarter results, lowering revenues and operating margins in all our businesses, although order growth held up well. We are doing our utmost to ensure the
BB Biotech: So geht Rendite mit COVID-19-Aktien!
Interessante Einblicke in den Geschäftsverlauf im Auftaktquartal liefert heute BB Biotech (WKN: A0NFN3). Die mussten zwar Rückschläge einstecken, glänzten aber auch durch Überraschungen – die mit
VFMCRP and Cara Therapeutics announce positive results from global KALM-2 pivotal phase-III trial of KORSUVA™ injection in haemodialysis patients with Pruritus
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200420005949/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
Five UBS Advisors in Greater New England Named to Barron's Top 1200 State by State Advisors List
UBS announced today that five Financial Advisors in the firm's Greater New England market, have been named to Barron's Top 1200 State by State Advisors list for 2020:
Timothy Connolly, Managing
Update on 92nd Vifor Pharma Ltd. Annual General Meeting
Regulatory News:
Vifor Pharma confirmed that it will hold its Annual General Meeting (AGM) on 14 May, 2020, as planned. In view of the current situation and based on Art. 6a of Ordinance 2
Update zur 92. Generalversammlung der Vifor Pharma AG
Regulatory News:
Vifor Pharma hat bestätigt, dass die Generalversammlung des Unternehmens wie geplant am 14. Mai 2020 abgehalten wird. Aufgrund der aktuellen Situation und im Einklang mit Art. 6a
ABB: COVID-19 Update
ABB is constantly monitoring the pandemic situation around COVID-19 (novel coronavirus). The health and safety of its employees, customers and partners remains the company’s number one priority and
ABB Shareholders Approve All Proposals At Annual General Meeting
The shareholders of ABB have approved all the proposals by the company’s Board of Directors at its 2020 Annual General Meeting held in Dübendorf, Switzerland. The event took place under